Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
According to our market capitalization data, Eli Lilly (LLY) reached a market cap of $678.07 billion, securing the top spot among global Biotech companies. Novo Nordisk A/S (NOVO-B.CO) and Johnson & Johnson (JNJ) follow closely behind. The data was last updated on January 22, 2025.
| Rank | Name | Market Cap | Price | MCap(30D) | MCap(1Y) | Country |
|---|---|---|---|---|---|---|
|
401
|
 Monte Rosa Therapeutics
GLUE
|
$0.34 B | $5.53 |
-19.8%
|
0.80%
|
United States
|
|
402
|
 Trevi Therapeutics
TRVI
|
$0.34 B | $3.78 |
-6.0%
|
178.5%
|
United States
|
|
403
|
 Cerus
CERS
|
$0.34 B | $1.81 |
13.3%
|
-2.7%
|
United States
|
|
404
|
 Neumora Therapeutics
NMRA
|
$0.34 B | $2.08 |
-80.7%
|
-87.4%
|
United States
|
|
405
|
 Precigen
PGEN
|
$0.33 B | $1.13 |
40.5%
|
-21.3%
|
United States
|
|
406
|
 Tango Therapeutics
TNGX
|
$0.33 B | $3.08 |
-6.3%
|
-74.9%
|
United States
|
|
407
|
 Sanara MedTech
SMTI
|
$0.33 B | $37.72 |
-6.6%
|
-7.0%
|
United States
|
|
408
|
 Medios AG
ILM1.DE
|
$0.32 B | $12.54 |
-5.5%
|
-18.6%
|
Germany
|
|
409
|
 Taysha Gene Therapies
TSHA
|
$0.31 B | $1.53 |
-17.3%
|
2.0%
|
United States
|
|
410
|
 Euroapi
EAPI.PA
|
$0.31 B | $3.26 |
10.3%
|
-50.1%
|
France
|
|
411
|
 Indoco Remedies
INDOCO.NS
|
$0.31 B | $3.32 |
-2.0%
|
-12.1%
|
India
|
|
412
|
 XOMA
XOMA
|
$0.31 B | $26.05 |
-1.4%
|
35.5%
|
United States
|
|
413
|
 Lexicon Pharmaceuticals
LXRX
|
$0.30 B | $0.84 |
-9.2%
|
-56.9%
|
United States
|
|
414
|
 Alimera Sciences
ALIM
|
$0.30 B | $5.54 |
0.00%
|
42.1%
|
United States
|
|
415
|
 Immutep
IMMP
|
$0.30 B | $1.96 |
-2.1%
|
-15.1%
|
Australia
|
|
416
|
 Aldeyra Therapeutics
ALDX
|
$0.30 B | $5.03 |
1.8%
|
57.7%
|
United States
|
|
417
|
 Amylyx Pharmaceuticals
AMLX
|
$0.30 B | $3.48 |
-10.0%
|
-75.4%
|
United States
|
|
418
|
 Voyager Therapeutics
VYGR
|
$0.30 B | $5.43 |
-12.3%
|
-33.0%
|
United States
|
|
419
|
 aTyr Pharma
ATYR
|
$0.29 B | $3.50 |
5.6%
|
134.4%
|
United States
|
|
420
|
 Design Therapeutics
DSGN
|
$0.29 B | $5.18 |
-20.3%
|
111.7%
|
United States
|
|
421
|
 OraSure Technologies
OSUR
|
$0.29 B | $3.89 |
-1.1%
|
-53.9%
|
United States
|
|
422
|
 Contineum Therapeutics
CTNM
|
$0.29 B | $11.21 |
-13.7%
|
-19.2%
|
United States
|
|
423
|
 Aquestive Therapeutics
AQST
|
$0.29 B | $3.14 |
-11.9%
|
24.0%
|
United States
|
|
424
|
 iTeos Therapeutics
ITOS
|
$0.28 B | $7.71 |
7.1%
|
-21.8%
|
United States
|
|
425
|
 Alpha Tau Medical
DRTS
|
$0.28 B | $3.99 |
31.1%
|
34.6%
|
Israel
|
|
426
|
 Rezolute
RZLT
|
$0.28 B | $4.81 |
10.4%
|
377.5%
|
United States
|
|
427
|
 Aclaris Therapeutics
ACRS
|
$0.28 B | $2.60 |
-11.4%
|
100.8%
|
United States
|
|
428
|
 Y-mAbs Therapeutics
YMAB
|
$0.28 B | $6.19 |
-24.4%
|
-36.8%
|
United States
|
|
429
|
 AC Immune
ACIU
|
$0.27 B | $2.71 |
-1.1%
|
-35.4%
|
Switzerland
|
|
430
|
 Eurobio Scientific
ALERS.PA
|
$0.26 B | $26.34 |
-0.20%
|
57.8%
|
France
|
|
431
|
 Atea Pharmaceuticals
AVIR
|
$0.26 B | $3.12 |
3.7%
|
-11.1%
|
United States
|
|
432
|
 Third Harmonic Bio
THRD
|
$0.26 B | $5.84 |
-43.9%
|
-39.5%
|
United States
|
|
433
|
 C4 Therapeutics
CCCC
|
$0.26 B | $3.71 |
1.8%
|
-30.1%
|
United States
|
|
434
|
 Silence Therapeutics
SLN
|
$0.26 B | $5.43 |
-19.9%
|
-70.2%
|
United Kingdom
|
|
435
|
 Atai Life Sciences
ATAI
|
$0.26 B | $1.52 |
22.0%
|
-18.0%
|
Germany
|
|
436
|
 Vanda Pharmaceuticals
VNDA
|
$0.25 B | $4.35 |
-9.7%
|
17.5%
|
United States
|
|
437
|
 Nautilus Biotechnology
NAUT
|
$0.25 B | $2.01 |
11.6%
|
-36.7%
|
United States
|
|
438
|
 Eledon Pharmaceuticals
ELDN
|
$0.25 B | $4.21 |
-5.9%
|
136.5%
|
United States
|
|
439
|
 Benitec Biopharma
BNTC
|
$0.25 B | $10.69 |
-11.1%
|
256.2%
|
United States
|
|
440
|
 Heron Therapeutics
HRTX
|
$0.25 B | $1.63 |
3.2%
|
-25.9%
|
United States
|
|
441
|
 Verastem Oncology
VSTM
|
$0.25 B | $5.52 |
36.7%
|
-50.4%
|
United States
|
|
442
|
 Perspective Therapeutics
CATX
|
$0.24 B | $3.60 |
5.5%
|
-27.0%
|
United States
|
|
443
|
 Foghorn Therapeutics
FHTX
|
$0.24 B | $4.37 |
-14.1%
|
32.6%
|
United States
|
|
444
|
 Sangamo Therapeutics
SGMO
|
$0.24 B | $1.15 |
-56.4%
|
142.2%
|
United States
|
|
445
|
 Lifecore Biomedical
LFCR
|
$0.24 B | $6.43 |
-14.7%
|
-0.77%
|
United States
|
|
446
|
 Neurogene
NGNE
|
$0.24 B | $15.95 |
-26.6%
|
-45.3%
|
United States
|
|
447
|
 ProQR
PRQR
|
$0.24 B | $2.23 |
-16.5%
|
10.9%
|
Netherlands
|
|
448
|
 Tevogen Bio
TVGN
|
$0.24 B | $1.35 |
19.6%
|
-88.7%
|
United States
|
|
449
|
 Avacta Group
AVCT.L
|
$0.23 B | $59.12 |
3.3%
|
-50.6%
|
United Kingdom
|
|
450
|
 Amarin Corporation
AMRN
|
$0.22 B | $0.55 |
23.9%
|
-52.9%
|
Ireland
|
|
451
|
 Abeona Therapeutics
ABEO
|
$0.22 B | $5.14 |
-8.1%
|
7.2%
|
United States
|
|
452
|
 Global Cord Blood
CORBF
|
$0.22 B | $1.12 |
0.00%
|
-32.7%
|
Hong Kong
|
|
453
|
 Avita Medical
RCEL
|
$0.22 B | $8.48 |
-33.0%
|
-42.6%
|
United States
|
|
454
|
 Larimar Therapeutics
LRMR
|
$0.22 B | $3.46 |
-11.6%
|
-25.8%
|
United States
|
|
455
|
 Fulcrum Therapeutics
FULC
|
$0.22 B | $4.09 |
-13.0%
|
-41.1%
|
United States
|
|
456
|
 Ocugen
OCGN
|
$0.22 B | $0.76 |
-1.1%
|
33.0%
|
United States
|
|
457
|
 Sera Prognostics
SERA
|
$0.22 B | $6.52 |
-19.2%
|
9.4%
|
United States
|
|
458
|
 Profound Medical
PROF
|
$0.22 B | $7.23 |
4.9%
|
-10.7%
|
Canada
|
|
459
|
 Compugen
CGEN
|
$0.22 B | $2.38 |
41.9%
|
21.4%
|
Israel
|
|
460
|
 Hester Biosciences
HESTERBIO.NS
|
$0.21 B | $25.14 |
-7.2%
|
47.8%
|
India
|
|
461
|
 4D Molecular Therapeutics
FDMT
|
$0.21 B | $4.61 |
-21.2%
|
-75.2%
|
United States
|
|
462
|
 Inventiva
IVA
|
$0.21 B | $2.17 |
-1.4%
|
-43.6%
|
France
|
|
463
|
 Sensorion SA
ALSEN.PA
|
$0.21 B | $0.70 |
7.1%
|
28.1%
|
France
|
|
464
|
 Monopar Therapeutics
MNPR
|
$0.21 B | $33.67 |
29.4%
|
1507.9%
|
United States
|
|
465
|
 Gossamer Bio
GOSS
|
$0.20 B | $0.90 |
14.0%
|
13.2%
|
United States
|
|
466
|
 ACELYRIN
SLRN
|
$0.20 B | $2.02 |
-37.2%
|
-71.0%
|
United States
|
|
467
|
 Bliss GVS Pharma
BLISSGVS.NS
|
$0.20 B | $1.92 |
1.2%
|
42.8%
|
India
|
|
468
|
 Cybin
CYBN
|
$0.20 B | $10.01 |
0.94%
|
-33.6%
|
Canada
|
|
469
|
 MediWound
MDWD
|
$0.20 B | $18.41 |
3.0%
|
41.1%
|
Israel
|
|
470
|
 Inhibrx
INBX
|
$0.20 B | $13.60 |
-6.9%
|
-21.6%
|
United States
|
|
471
|
 Molecular Partners
MOLN
|
$0.20 B | $5.33 |
-0.19%
|
15.2%
|
Switzerland
|
|
472
|
 Orchestra BioMed
OBIO
|
$0.20 B | $5.16 |
12.3%
|
-43.9%
|
United States
|
|
473
|
 MacroGenics
MGNX
|
$0.19 B | $3.08 |
-8.0%
|
-75.0%
|
United States
|
|
474
|
 Procaps Group
PROC
|
$0.19 B | $1.69 |
-34.7%
|
-61.4%
|
Luxembourg
|
|
475
|
 Vaxart
VXRT
|
$0.19 B | $0.82 |
21.3%
|
-7.5%
|
United States
|
|
476
|
 Genfit
GNFT
|
$0.18 B | $3.60 |
-1.9%
|
-7.5%
|
France
|
|
477
|
 Oriola Oyj
OKDAV.HE
|
$0.18 B | $1.00 |
5.5%
|
-13.1%
|
Finland
|
|
478
|
 Nkarta
NKTX
|
$0.18 B | $2.48 |
5.1%
|
-68.8%
|
United States
|
|
479
|
 Amplitude Surgical SA
AMPLI.PA
|
$0.17 B | $3.54 |
9.0%
|
1.8%
|
France
|
|
480
|
 Nightingale Health Oyj
HEALTH.HE
|
$0.17 B | $2.89 |
-1.1%
|
142.9%
|
Finland
|
|
481
|
 Protalix BioTherapeutics
PLX
|
$0.17 B | $2.37 |
30.9%
|
50.3%
|
Israel
|
|
482
|
 Acrivon Therapeutics
ACRV
|
$0.17 B | $5.60 |
-7.2%
|
36.0%
|
United States
|
|
483
|
 Alector
ALEC
|
$0.17 B | $1.78 |
-7.6%
|
-72.1%
|
United States
|
|
484
|
 Idorsia
IDIA.SW
|
$0.17 B | $0.91 |
1.3%
|
-36.8%
|
Switzerland
|
|
485
|
 INmune Bio
INMB
|
$0.17 B | $7.67 |
43.7%
|
-41.7%
|
United States
|
|
486
|
 Nektar Therapeutics
NKTR
|
$0.17 B | $0.92 |
-2.2%
|
74.5%
|
United States
|
|
487
|
 Lyell Immunopharma
LYEL
|
$0.17 B | $0.58 |
-6.0%
|
-72.6%
|
United States
|
|
488
|
 Greenwich LifeSciences
GLSI
|
$0.17 B | $12.71 |
5.4%
|
48.3%
|
United States
|
|
489
|
 ADC Therapeutics
ADCT
|
$0.16 B | $1.70 |
-13.3%
|
-10.7%
|
Switzerland
|
|
490
|
 Vor Biopharma
VOR
|
$0.16 B | $1.31 |
52.0%
|
-43.2%
|
United States
|
|
491
|
 Protara Therapeutics
TARA
|
$0.16 B | $4.69 |
-12.0%
|
132.1%
|
United States
|
|
492
|
 Sutro Biopharma
STRO
|
$0.16 B | $1.97 |
4.1%
|
-58.2%
|
United States
|
|
493
|
 Lexeo Therapeutics
LXEO
|
$0.16 B | $4.90 |
-20.2%
|
-70.4%
|
United States
|
|
494
|
 Zentalis Pharmaceuticals
ZNTL
|
$0.16 B | $2.26 |
-30.4%
|
-83.6%
|
United States
|
|
495
|
 Cellectis S.A.
ALCLS.PA
|
$0.16 B | $1.59 |
4.8%
|
-41.2%
|
France
|
|
496
|
 scPharmaceuticals
SCPH
|
$0.16 B | $3.21 |
-3.0%
|
-40.0%
|
United States
|
|
497
|
 Akoya Biosciences
AKYA
|
$0.16 B | $3.21 |
17.0%
|
-43.8%
|
United States
|
|
498
|
 Cellectis
CLLS
|
$0.16 B | $1.53 |
18.6%
|
-36.0%
|
France
|
|
499
|
 Seres Therapeutics
MCRB
|
$0.16 B | $0.91 |
-20.1%
|
-36.6%
|
United States
|
|
500
|
 Ventyx Biosciences
VTYX
|
$0.15 B | $2.16 |
-11.0%
|
0.00%
|
United States
|
|
501
|
 Fate Therapeutics
FATE
|
$0.15 B | $1.34 |
-23.5%
|
-73.7%
|
United States
|
|
502
|
 Veru
VERU
|
$0.15 B | $1.04 |
55.6%
|
139.0%
|
United States
|
|
503
|
 Nanobiotix
NBTX
|
$0.15 B | $3.21 |
-3.7%
|
-62.6%
|
France
|
|
504
|
 Coherus BioSciences
CHRS
|
$0.15 B | $1.31 |
-5.4%
|
-42.1%
|
United States
|
|
505
|
 Innate Pharma
IPHA
|
$0.15 B | $1.77 |
-14.1%
|
-32.4%
|
France
|
|
506
|
 Lineage Cell Therapeutics
LCTX
|
$0.15 B | $0.68 |
9.3%
|
-43.3%
|
United States
|
|
507
|
 Telomir Pharmaceuticals
TELO
|
$0.15 B | $4.98 |
-5.6%
|
-6.2%
|
United States
|
|
508
|
 InflaRx
IFRX
|
$0.15 B | $2.50 |
-1.6%
|
43.6%
|
Germany
|
|
509
|
 Adaptimmune Therapeutics
ADAP
|
$0.15 B | $0.57 |
7.1%
|
-18.4%
|
United Kingdom
|
|
510
|
 Inotiv
NOTV
|
$0.15 B | $4.41 |
-5.7%
|
23.1%
|
United States
|
|
511
|
 Sight Sciences
SGHT
|
$0.15 B | $2.88 |
-20.3%
|
-46.8%
|
United States
|
|
512
|
 Biodesix
BDSX
|
$0.15 B | $1.00 |
-21.2%
|
-41.9%
|
United States
|
|
513
|
 Puma Biotechnology
PBYI
|
$0.14 B | $2.95 |
-1.7%
|
-40.7%
|
United States
|
|
514
|
 TScan Therapeutics
TCRX
|
$0.14 B | $2.52 |
-17.5%
|
-52.4%
|
United States
|
|
515
|
 Kyverna Therapeutics
KYTX
|
$0.14 B | $3.29 |
-15.9%
|
-88.9%
|
United States
|
|
516
|
 Seer
SEER
|
$0.14 B | $2.37 |
3.6%
|
39.6%
|
United States
|
|
517
|
 Corbus Pharmaceuticals
CRBP
|
$0.14 B | $11.35 |
-9.5%
|
63.3%
|
United States
|
|
518
|
 Sagimet Biosciences
SGMT
|
$0.14 B | $4.25 |
-11.1%
|
-74.9%
|
United States
|
|
519
|
 2seventy bio
TSVT
|
$0.13 B | $2.52 |
-13.9%
|
-15.8%
|
United States
|
|
520
|
 Instil Bio
TIL
|
$0.13 B | $19.72 |
-4.2%
|
96.3%
|
United States
|
|
521
|
 Renovaro Biosciences
RENB
|
$0.13 B | $0.80 |
-31.4%
|
-84.8%
|
United States
|
|
522
|
 Solid Biosciences
SLDB
|
$0.12 B | $3.12 |
-21.8%
|
-58.1%
|
United States
|
|
523
|
 Cassava Sciences
SAVA
|
$0.12 B | $2.59 |
17.5%
|
-89.4%
|
United States
|
|
524
|
 Cabaletta Bio
CABA
|
$0.12 B | $2.54 |
17.1%
|
-86.4%
|
United States
|
|
525
|
 Zomedica Pharmaceuticals
ZOM
|
$0.12 B | $0.13 |
8.3%
|
-2.3%
|
United States
|
|
526
|
 Alto Neuroscience
ANRO
|
$0.12 B | $4.52 |
13.4%
|
-77.6%
|
United States
|
|
527
|
 Atossa Therapeutics
ATOS
|
$0.12 B | $0.96 |
-19.4%
|
1.2%
|
United States
|
|
528
|
 Nuvectis Pharma
NVCT
|
$0.12 B | $6.10 |
18.1%
|
-22.6%
|
United States
|
|
529
|
 Zura Bio
ZURA
|
$0.12 B | $1.79 |
-23.7%
|
-55.5%
|
United States
|
|
530
|
 XBiotech
XBIT
|
$0.11 B | $3.77 |
-16.2%
|
-16.0%
|
United States
|
|
531
|
 Carbios SAS
ALCRB.PA
|
$0.11 B | $6.76 |
-7.4%
|
-73.1%
|
France
|
|
532
|
 Metagenomi
MGX
|
$0.11 B | $3.03 |
-30.8%
|
-74.7%
|
United States
|
|
533
|
 Nanoform Finland Oyj
NANOFH.HE
|
$0.11 B | $1.31 |
-1.1%
|
-39.6%
|
Finland
|
|
534
|
 Editas Medicine
EDIT
|
$0.11 B | $1.34 |
0.83%
|
-85.4%
|
United States
|
|
535
|
 Enanta Pharmaceuticals
ENTA
|
$0.11 B | $5.18 |
-13.9%
|
-56.9%
|
United States
|
|
536
|
 Genelux
GNLX
|
$0.11 B | $3.15 |
2.9%
|
-78.6%
|
United States
|
|
537
|
 Milestone Pharmaceuticals
MIST
|
$0.11 B | $1.99 |
15.7%
|
39.0%
|
Canada
|
|
538
|
 electroCore
ECOR
|
$0.11 B | $16.11 |
-2.2%
|
115.4%
|
United States
|
|
539
|
 Achieve Life Sciences
ACHV
|
$0.11 B | $3.07 |
-24.8%
|
-38.4%
|
Canada
|
|
540
|
 Acumen Pharmaceuticals
ABOS
|
$0.11 B | $1.75 |
-7.8%
|
-50.5%
|
United States
|
|
541
|
 Aiforia Technologies Oyj
AIFORIA.HE
|
$0.10 B | $3.61 |
-0.84%
|
-6.1%
|
Finland
|
|
542
|
 Eurofins-Cerep SA
ALECR.PA
|
$0.10 B | $20408.16 |
0.00%
|
-21.6%
|
France
|
|
543
|
 Nectar Lifesciences
NECLIFE.NS
|
$0.10 B | $0.45 |
-3.2%
|
7.5%
|
India
|
|
544
|
 DBV Technologies
DBVT
|
$0.10 B | $4.74 |
63.5%
|
182.4%
|
France
|
|
545
|
 Tenaya Therapeutics
TNYA
|
$0.10 B | $1.28 |
-15.7%
|
-69.3%
|
United States
|
|
546
|
 IGM Biosciences
IGMS
|
$0.10 B | $1.70 |
-72.3%
|
-85.2%
|
United States
|
|
547
|
 Allakos
ALLK
|
$0.10 B | $1.12 |
-32.3%
|
-27.1%
|
United States
|
|
548
|
 Adocia SA
ADOC.PA
|
$99.69 M | $6.25 |
3.4%
|
-43.2%
|
France
|
|
549
|
 MDxHealth
MDXH
|
$99.49 M | $2.01 |
-6.6%
|
-48.6%
|
Belgium
|
|
550
|
 Crossject SA
ALCJ.PA
|
$99.27 M | $2.17 |
-2.8%
|
-60.0%
|
France
|
|
551
|
 Median Technologies SA
ALMDT.PA
|
$98.57 M | $5.23 |
36.3%
|
30.8%
|
France
|
|
552
|
 DBV Technologies S.A.
DBV.PA
|
$96.53 M | $0.92 |
37.4%
|
-49.4%
|
France
|
|
553
|
 Anixa Biosciences
ANIX
|
$95.79 M | $2.97 |
-6.6%
|
-50.8%
|
United States
|
|
554
|
 ALX Oncology
ALXO
|
$94.94 M | $1.80 |
-4.9%
|
-87.2%
|
United States
|
|
555
|
 HilleVax
HLVX
|
$94.63 M | $1.90 |
1.6%
|
-87.3%
|
United States
|
|
556
|
 Coya Therapeutics
COYA
|
$94.56 M | $5.66 |
-0.65%
|
-8.0%
|
United States
|
|
557
|
 Oramed Pharmaceuticals
ORMP
|
$93.12 M | $2.31 |
-4.2%
|
-0.44%
|
United States
|
|
558
|
 Adverum Biotechnologies
ADVM
|
$92.99 M | $4.47 |
-8.6%
|
-49.9%
|
United States
|
|
559
|
 Pyxis Oncology
PYXS
|
$92.77 M | $1.56 |
-6.3%
|
-52.1%
|
United States
|
|
560
|
 23andMe
ME
|
$92.20 M | $3.53 |
13.9%
|
-74.3%
|
United States
|
|
561
|
 Entera Bio
ENTX
|
$91.71 M | $2.49 |
10.3%
|
172.7%
|
Israel
|
|
562
|
 Fractyl Health
GUTS
|
$90.43 M | $1.88 |
-6.3%
|
-86.0%
|
United States
|
|
563
|
 BioPorto A/S
BIOPOR.CO
|
$90.17 M | $0.21 |
6.7%
|
-29.7%
|
Denmark
|
|
564
|
 Jasper Therapeutics
JSPR
|
$90.16 M | $6.01 |
-74.6%
|
-49.6%
|
United States
|
|
565
|
 MediciNova
MNOV
|
$88.77 M | $1.81 |
-11.6%
|
23.6%
|
United States
|
|
566
|
 Immunic
IMUX
|
$88.60 M | $0.98 |
-9.2%
|
-16.4%
|
United States
|
|
567
|
 Leap Therapeutics
LPTX
|
$88.13 M | $2.30 |
-12.4%
|
-10.5%
|
United States
|
|
568
|
 Rani Therapeutics
RANI
|
$87.24 M | $1.49 |
-7.7%
|
-64.3%
|
United States
|
|
569
|
 I-Mab Biopharma
IMAB
|
$87.21 M | $1.07 |
18.9%
|
-38.7%
|
China
|
|
570
|
 Agenus
AGEN
|
$86.42 M | $3.66 |
26.5%
|
-71.0%
|
United States
|
|
571
|
 Karyopharm Therapeutics
KPTI
|
$84.09 M | $0.67 |
10.9%
|
-22.4%
|
United States
|
|
572
|
 Inozyme Pharma
INZY
|
$83.51 M | $1.30 |
-53.6%
|
-70.2%
|
United States
|
|
573
|
 VistaGen Therapeutics
VTGN
|
$83.25 M | $2.99 |
14.5%
|
-41.0%
|
United States
|
|
574
|
 X4 Pharmaceuticals
XFOR
|
$83.21 M | $0.49 |
-12.4%
|
-32.2%
|
United States
|
|
575
|
 Vigil Neuroscience
VIGL
|
$82.99 M | $2.03 |
18.4%
|
-36.7%
|
United States
|
|
576
|
 Tiziana Life Sciences
TLSA
|
$82.74 M | $0.80 |
7.2%
|
25.4%
|
United Kingdom
|
|
577
|
 Inovio Pharmaceuticals
INO
|
$81.23 M | $2.25 |
13.7%
|
-70.1%
|
United States
|
|
578
|
 Regulus Therapeutics
RGLS
|
$81.22 M | $1.24 |
-19.5%
|
1.6%
|
United States
|
|
579
|
 Scilex Holding
SCLX
|
$80.63 M | $0.44 |
6.9%
|
-72.5%
|
United States
|
|
580
|
 Sellas Life Sciences
SLS
|
$80.24 M | $1.14 |
14.0%
|
103.8%
|
United States
|
|
581
|
 Adagene
ADAG
|
$79.69 M | $1.80 |
-5.2%
|
-43.3%
|
China
|
|
582
|
 Theratechnologies
THTX
|
$79.42 M | $1.72 |
-3.3%
|
2.9%
|
Canada
|
|
583
|
 Armata Pharmaceuticals
ARMP
|
$79.24 M | $2.19 |
0.98%
|
-47.2%
|
United States
|
|
584
|
 InterCure
INCR
|
$78.72 M | $1.72 |
1.5%
|
38.0%
|
Israel
|
|
585
|
 Skye Bioscience
SKYE
|
$78.58 M | $2.59 |
4.3%
|
15.7%
|
United States
|
|
586
|
 Nykode Therapeutics
NYKD.OL
|
$78.42 M | $0.24 |
-8.3%
|
-85.5%
|
Norway
|
|
587
|
 Assertio Therapeutics
ASRT
|
$77.34 M | $0.81 |
-5.7%
|
-2.4%
|
United States
|
|
588
|
 Journey Medical
DERM
|
$76.87 M | $3.68 |
-18.5%
|
-33.1%
|
United States
|
|
589
|
 Adlai Nortye
ANL
|
$76.84 M | $2.08 |
-12.7%
|
-78.0%
|
|
|
590
|
 Cue Biopharma
CUE
|
$76.65 M | $1.21 |
29.7%
|
-53.9%
|
United States
|
|
591
|
 bluebird bio
BLUE
|
$76.22 M | $7.84 |
7.2%
|
-64.3%
|
United States
|
|
592
|
 Galectin Therapeutics
GALT
|
$75.94 M | $1.21 |
47.6%
|
-27.9%
|
United States
|
|
593
|
 ESSA Pharma
EPIX
|
$75.90 M | $1.71 |
8.1%
|
-79.6%
|
Canada
|
|
594
|
 Adicet Bio
ACET
|
$75.64 M | $0.92 |
-0.87%
|
-63.8%
|
United States
|
|
595
|
 Aadi Bioscience
AADI
|
$73.80 M | $2.99 |
-0.67%
|
71.3%
|
United States
|
|
596
|
 Annovis Bio
ANVS
|
$73.26 M | $5.31 |
0.00%
|
-57.0%
|
United States
|
|
597
|
 Aerovate Therapeutics
AVTE
|
$73.14 M | $2.53 |
-0.77%
|
-87.3%
|
United States
|
|
598
|
 Applied Therapeutics
APLT
|
$73.12 M | $0.63 |
-23.4%
|
-75.8%
|
United States
|
|
599
|
 Genenta Science
GNTA
|
$72.98 M | $3.99 |
-23.4%
|
-9.3%
|
Italy
|
|
600
|
 Clearside Biomedical
CLSD
|
$72.42 M | $0.95 |
0.11%
|
-22.5%
|
United States
|